Kim Francis Y, Soto-Campos Gerardo, Palumbo Jamie, Newth Christopher J L, Rice Tom B
Department of Pediatrics, Section Pediatric Critical Care Medicine, Helen DeVos Children's Hospital - Corewell Health. Michigan State University College of Human Medicine, Grand Rapids, MI.
Department of Analytics, Virtual Pediatric Systems, LLC, Los Angeles, CA.
Pediatr Crit Care Med. 2025 Mar 1;26(3):e364-e373. doi: 10.1097/PCC.0000000000003654. Epub 2024 Nov 21.
Extubation failure (EF) in PICU patients is reintubation within 48, 72, or 96 hours of planned extubation (EF48, EF72, and EF96, respectively). Standardized sedation protocols, extubation readiness testing, and noninvasive respiratory support are used to improve efficient liberation from mechanical ventilation (MV). We therefore aimed to review EF rates, time to failure, and the use of noninvasive respiratory support after extubation, 2017-2021.
Retrospective analysis of patients admitted to PICUs contributing to the Virtual Pediatric Systems (VPS, LLC) database, 2017-2021.
One hundred thirty-six participating PICUs.
All patients admitted to participating PICUs between January 1, 2017, and December 31, 2021, who had MV and met inclusion criteria for planned extubation.
None.
There were 111,229 planned extubations with 5,143 reintubations within 48 hours. The EF48, EF72, and EF96 rates were 4.6%, 5.3%, and 5.8%, respectively. Higher rates of EF were associated with age younger than 6 months, underlying genetic conditions, medical comorbidities, or cardiac surgery. Failed extubation was also associated with higher Pediatric Risk of Mortality III scores, longer duration of MV, and longer PICU and hospital lengths of stay. From 2017 to 2021, there was an increase in the use of high-flow nasal cannula oxygen therapy after extubation from 16.6% to 20.2%.
In the VPS 2017-2021 dataset, we have found that the overall EF rates (EF48-EF96) have improved over this 5-year period. We are not able to assess the clinical benefit of this change, but it is evident that over the same period, there has been a concomitant increase in the use of postextubation noninvasive respiratory support. Further work is needed to look at the interaction of these effects in contemporary PICU practice.
儿科重症监护病房(PICU)患者拔管失败(EF)定义为计划拔管后48、72或96小时内再次插管(分别为EF48、EF72和EF96)。标准化镇静方案、拔管准备测试和无创呼吸支持用于提高机械通气(MV)撤机效率。因此,我们旨在回顾2017 - 2021年期间的EF发生率、失败时间以及拔管后无创呼吸支持的使用情况。
对2017 - 2021年贡献于虚拟儿科系统(VPS,LLC)数据库的PICU收治患者进行回顾性分析。
136个参与研究的PICU。
2017年1月1日至2021年12月31日期间入住参与研究的PICU且接受MV并符合计划拔管纳入标准的所有患者。
无。
共有111,229次计划拔管,其中48小时内有5,143次再次插管。EF48、EF72和EF96的发生率分别为4.6%、5.3%和5.8%。较高的EF发生率与6个月以下年龄、潜在遗传疾病、内科合并症或心脏手术有关。拔管失败还与较高的儿科死亡风险Ⅲ评分、较长的MV持续时间以及较长的PICU和住院时间有关。从2017年到2021年,拔管后高流量鼻导管吸氧治疗的使用从16.6%增加到20.2%。
在VPS 2017 - 2021数据集里,我们发现这5年期间总体EF发生率(EF48 - EF96)有所改善。我们无法评估这一变化的临床益处,但很明显,同期拔管后无创呼吸支持的使用也随之增加。需要进一步研究以探讨这些效应在当代PICU实践中的相互作用。